Inovio Pharmaceuticals Inc (#INO) Stock Price, Live Chart & Analysis | Trade #INO
Inovio Pharmaceuticals Inc., founded in 1983, is an American biotechnology company focused on developing DNA immunotherapeutic medical products. It is headquartered near Plymouth, Pennsylvania, USA. Initially, the company's name was Biotechnologies & Experimental Research, but after the purchase of the Norwegian Inovio AS in 2005, it was changed to Inovio Pharmaceuticals.
The list of the company's products includes medicines for Ebola and HIV and medicines for the treatment and prevention of cancer. Inovio Pharmaceuticals is also known for its participation in developing a vaccine against COVID-19.
The #INO rate largely depends on the company's success and the demand for its drugs on the market. For example, when the company announced the effectiveness of its coronavirus vaccine in 2020, its stock price rose significantly. However, that same year, the value of #INO plummeted, and Inovio Pharmaceuticals could not outperform competitors such as Moderna, Johnson & Johnson, and Pfizer.
When trading #INO, following the company's news is important. Successful acquisitions or launches of new drugs are considered bullish for Inovio Pharmaceuticals stock. On the contrary, the closure of divisions or litigation leads to a fall in the stock price. In 2020, for example, Inovio Pharmaceuticals faced numerous class action lawsuits. The company was accused of misleading shareholders by announcing the readiness of a coronavirus vaccine. As a result, the price of #INO has been falling for several weeks.
Risk warning: Trading in FX and CFDs entails high risk of losing capital.
Are you interested in buying Inovio Pharmaceuticals Inc (#INO)? It’s easy!
SellBuyActive SellActive Buy
| Sell | 7.2 |
| Buy | 7.25 |
| Sentiment | 100% ▾ |
| 1-day change | -3.11(-30.16%) |
Earn from the fluctuations of prices and boost your income with LiteFinance!
#INO (#INO) shares’ cost is $7.25 for today. The highest rate of shares #INO (#INO) for today is $7.5499, the lowest price is $7.1300. The opening price was $7.41.
A real-time chart for #INO (#INO) shares quote is provided below.
Price chart of #INO in real time mode
Available in trading accounts:
- ECN
- CLASSIC
Prev. Close7.32
Day's Range7.1300 - 7.5499
Opening7.41
52 wk Range3.888-14.748
Volume207,354
Shares Outstanding25,964,268
Average Volume361,218
Market Cap187.46M
1-Year Return33.26%
EPS-5.09
Beta0.894
Revenue591.86K
P/E Ratio-1.41
DividendsN/A(N/A)
Next Earnings Daten/a
Spread0
Swap Long-6
Contract size1
Swap Short2.5
Stop&Limit Level0
| #AAPL | N/A | N/A | 4.9 | 2.19% |
| #CSCO | N/A | N/A | 2.16 | 4.46% |
| #META | N/A | N/A | -3.08 | -0.59% |
| #PANW | N/A | N/A | 39.07 | 12.11% |
| #INTC | N/A | N/A | -8.45 | -27.70% |
| #MSFT | N/A | N/A | -9.69 | -2.27% |
| #GOOG | N/A | N/A | -10.39 | -5.92% |
| #PEP | N/A | N/A | 0.2 | 0.12% |
| #PYPL | N/A | N/A | 5.58 | 8.35% |
| #NVDA | N/A | N/A | 0.5 | 0.42% |
| #TSLA | N/A | N/A | -14.35 | -6.28% |
| #SBUX | N/A | N/A | 18.33 | 24.04% |
| #AMGN | N/A | N/A | -4.68 | -1.38% |
| #CL | N/A | N/A | 7.18 | 7.24% |
| #ZM | N/A | N/A | 8.54 | 14.12% |
| #GILD | N/A | N/A | 2.98 | 3.92% |
| #AGNC | N/A | N/A | 0.16 | 1.60% |
| #MRNA | N/A | N/A | -23.92 | -23.62% |
| #OKTA | N/A | N/A | -13.61 | -14.75% |
| #DOCU | N/A | N/A | 4.97 | 9.16% |
| #AMZN | N/A | N/A | -11.56 | -6.08% |
| #EBAY | N/A | N/A | 3.4 | 6.11% |
| #ADP | N/A | N/A | 14.28 | 5.46% |
| #DBX | N/A | N/A | 1.39 | 5.85% |
| #PDD | N/A | N/A | -34.01 | -26.13% |
| #MDLZ | N/A | N/A | 3.97 | 5.85% |
| #TRIP | N/A | N/A | -2.96 | -16.96% |
| #BKNG | N/A | N/A | 183.17 | 4.92% |
| #EXPE | N/A | N/A | 14.83 | 11.94% |
| #POOL | N/A | N/A | -21.96 | -5.88% |
| #LCID | N/A | N/A | 0.58 | 16.91% |
| #COIN | N/A | N/A | -41.5 | -18.46% |
| #LRCX | N/A | N/A | -49.82 | -5.72% |
| #AVGO | N/A | N/A | 4.4 | 2.79% |
| #INO | N/A | N/A | -3.11 | -30.16% |
| #AMD | N/A | N/A | 6.06 | 4.25% |
| #QCOM | N/A | N/A | 3.2 | 1.86% |
Interesting facts about the #INO (Inovio Pharmaceuticals Inc)
Inovio Pharmaceuticals stocks are highly volatile. During the global fight against COVID-19, the value of #INO updated its multi-year highs. The profitability of the company's shares reached 470%. However, then the price fell to historic lows. With proper market analysis, traders can make a lot of profit from such price fluctuations.
Inovio Pharmaceuticals often receives large grants for its developments. The Gates Foundation, the Coalition for Epidemic Preparedness Innovations (CEPI), and the US Department of Defense are among the company's top backers. News of donations from major organizations has a positive impact on the reputation of Inovio Pharmaceuticals and its stock price.
Suspension of research or testing of new drugs negatively affects the course of #INO. In the fall of 2020, stocks of Inovio Pharmaceuticals lost 39.3% after the company's management announced a partial suspension of clinical trials of a vaccine against COVID-19.
The activities of Inovio Pharmaceuticals depend on the actions of regulators. Official statements from the US Department of Health forced investors to invest in more well-known and reliable assets, such as Moderna, Johnson & Johnson, and Pfizer stocks. At some point, the company even had to suspend its research. As a result, Inovio Pharmaceuticals' market capitalization fell, and its stocks depreciated.
Follow us in social networks!
Live Chat
Leave a feedback